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Defective reticuloendothelial Fc receptor specific function associated
with lILA B8—DR3 haplotype in idiopathic membranous glomeruloneph-
ntis. E. McGinley, N. Henderson, W. Marlin, and M. Boulton Jones.
Renal Unit, Royal Infirmary, Glasgow, Scotland. There has been a
reported association between the HLA B8-DR3 haplotype and defec-
tive reticuloendotheial (RE) Fc receptor specific function in patients
with dermatitis herpetiformis and normal subjects. The HLA B8-DR3
haplotype has also been associated with idiopathic membranous gb-
merulonephritis (IMGN). We wished to study whether there was any
abnormality of RE Fc receptor function in patients with IMGN and
whether or not this was related to the HLA haplotype. To measure RE
Fc receptor function, we coated autologous erythrocytes with a known
concentration of standard rhesus anti-D IgC and labelled the cells with
Tcw. Blood clearance was measured at T'/2 of a single exponential,
and the normal range was 31 to 60 mm in 9 controls. We compared this
test with another which also measured the predominantly splenic RE
function, namely the clearance of autobogous heat-damaged erythro-
cytes (HDE) labelled with Tcm. A comparison of the kinetics of
clearance of both tests allowed an assessment of splenic blood flow to
be made. Fifteen rhesus D positive patients with IMGN were studied.
Ten of these patients had HLA DR3 antigen, and nine of these patients
had a delayed clearance of IgG-coated cells. The remaining five patients
had either HLA DR2 or DR4 antigens and normal clearances of the LgG-
coated cells. All fifteen patients had a normal clearance of HDE as did a
further three rhesus D negative patients who had DR2 haplotype.
Immune complexes were not detected in ten patients by Clq and
rheumatoid factor binding. This study of IMGN supports the associa-
tion between HLA DR3 and defective RE function. It is likely that the
defect is related to a reduced expression of RE Fc receptors and not due
to a RE blockade, nor due to defects in splenic blood flow because
circulating immune complexes were not detected and clearance mecha-
nisms of HDE were normal even in patients with delayed clearance of
opsonized cells. Defective RE function linked with the HLA type could
be an important factor in the pathogenesis of IMGN, a putative immune
complex mediated disease.
IgG turnover studies in patients with cryoglobulinemia. J. A. Schifferli,
N. Amos, C. D. Pusey, J. G. P. Sissons, and D. K. Peters. Department
of Medicine, Royal Postgraduate Medical School, Hammersmith Hos-
pital, London, England. The variable rate of reappearance of plasma
cryoglobulins after a plasma exchange in mixed essential cryoglobuline-
mia stimulated studies of their turnover. Data on 4 patients with
monoclonal 1gM kappa and polyclonal IgG cryoglobulinemia are pre-
sented. The patients were injected with radiolabelled normal IgG (N-
IgG) and IgG purified from their cryoglobulin (Cr-IgG) to determine if
their own Cr-IgG had faster catabolism than N-IgG, which might be the
case if Cr-IgG was altered or combined to an unknown antigen before
being recognized efficiently by the monoclonal 1gM. The results are
shown:
Patient
IgG concentration
mg/mi
Fractional catabolic
rate (FCR), %/day
Synthetic rate
mg/kg/day
1. N-IgG
Cr-IgG
107. 9.610.8
51
56
2. N-IgG
Cr-lgG
100 13.213.9
38
40
3. N-IgG
Cr-IgG
6. 6.27.9
14
24
4. N-IgG
Cr-IgG
5 3.44,0 0.81.0
Normal range 6—16 4.3—9.8 20—60
There was no clearcut difference in the FCR or synthetic rate between
the N-IgG and Cr-IgG, and there was surprisingly little or no increase in
Cr-IgG turnover in 3 patients. A fourth patient had hypogammaglobu-
linemia. All his IgG was combined in vivo with 1gM as shown by gel
filtration on sepharose 6B at 37°C by polyethylene glycol precipitation
at 37°C and by a sucrose density gradient ultracentrifugation, but the
fractional catabolic rate of N-IgG and Cr-IgG was reduced; the synthet-
ic rates were low. In conclusion, these data suggest that cryoglobulins
may be slowly cleared, that the difference between the catabolism of
Cr-IgG and N-IgG is small, and that in one patient the generation of
IgG-IgM complexes was associated with the depletion of IgG synthesis.
Phagocytosls by mesangial cells and blood monocytes during uptake
and clearance of ferritin by the glomerular mesangium. V. Cattell, A. de
Urdaneta, S. Arlidge, and J. Smith. Department of Experimental
Pathology, St. Ma,y's Hospital Medical School, London, England. The
exact site of localization of macromolecules in the mesangium, the
nature of 'mesangial' phagocytosis, and the fate of deposited material
have been studied using i.v. ferritin (Fe) as an electron-dense tracer and
polyvinyl alcohol (PVA) as an inert lysosomal marker. PVA was given
daily (50 mgIlOO g body wt s.c.) to donor Lewis rats for one month.
PVA-loaded kidneys were transplanted into syngeneic rats, who were
then given a single i.v. Fe injection (150 mg/l00 g body wt) one week
after transplantation. The passage of Fe in the recipients' own right
kidneys and in PVA-transplants was followed by electron microscopy
of repeated renal biopsies taken from 10 mm to 10 days after transplan-
tation. PVA was taken up by phagosomes throughout the reticuloendo-
thelial system, and marked phagosomes in cells in the mesangium.
PVA-containing vacuoles were seen in mesangial cells, and in globular
cells resident in the mesangium at the time of transplantation. From 10
mm onward, increasing amounts of Fe were seen in mesangial cell
vacuoles. Four hours after the introduction of Fe into the kidneys,
intraluminal monocytes laden with Fe were found. In PVA-loaded
kidneys these cells could be identified as newly infiltrating the mesan-
gium because they did not contain PVA. This process of monocyte
accumulation increased by 24 hours when some loops were occluded by
4 to 5 monocytes. In mesangial cells and monocyte vacuoles Fe
particles lost their discrete appearance from 24 hours onward. From 4
to 10 days after the introduction of Fe into the kidneys, there were only
a few solitary intraluminal cells; the mesangial regions of the animals'
own kidneys did not contain detectable monocytes. Lacis cells also
phagocytosed and degraded Fe but in smaller amounts than the
mesangium. No infiltrating monocytes were seen in this region. We
conclude that mesangial localization of macromolecules is accompanied
by significant monocyte infiltration and that intralysosomal degradation
by both mesangial cells and monocytes is a major mechanism of
mesangial clearance.
Prednisolone therapy in patients with membranous nephropathy and
declining renal function. C. D. Short, L. R. Solomon, and N. P. Mallick.
Department of Renal Medicine, Manchester Royal Infirmary, Man-
chester, England. Five consecutive male patients, aged 24 to 58 years,
with membranous nephropathy and a steadily rising plasma creatinine
in the presence of a stable plasma albumin, were first given steroid
therapy between November 1980 and April 1981. We gave methyl-
prednisolone I g i.v. daily for 5 days, then 100 mg prednisolone orally
on alternate days, reducing the dosage to 20mg on alternate days within
approximately 4 months. The changes in renal function are shown:
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Plasma Maximum Minimum
creatinine plasma plasma Weeks since
Patient at first creatininea creatinine therapy
no. assessment before treatment after treatment started
1 0.11 0.37 0.20 15
2 0.09 0.70 0.54 22
3 0.35 0.48 0.17 19
4 0.10 0.40 0.14 10
5 0.08 0.37 0.18 19
Plasma creatinine in mmoles/liter.
All subjects originally presented with the nephrotic syndrome. In 4
patients, between 19 and 41 months elapsed from presentation before
declining renal function was apparent, and a further 17 to 26 months
passed before treatment was started. No patient was HBsAg positive,
had received drugs known to cause membranous change, or has
manifested a previously occult neoplasm. One patient had raised anti-
dsDNA antibodies but no other systemic or serological markers of
lupus; a second had pulmonary sarcoidosis which resolved spontane-
ously many months before the decline in function was apparent; a third
had a benign paraproteinemia. Despite a temporal relationship between
the treatment of these patients and a reversal of the decline in renal
function, proteinuria has persisted at more than 6 g/24 hours in all of
them.
Reduction of proteinuria following plasma exchange in recurrent renal
allograft focal glomeruloscierosis. Y. Willassen. University of Bergen,
School of Medicine, Bergen, Norway. Recurrence of the proteinuria of
focal segmental glomerulosclerosis has been reported to occur in the
immediate posttransplant period in patients with renal allografts. These
observations support the idea that circulating humoral substances
interfere with the function of the glomerular capillary membrane in
these patients, increasing the glomerular permeability to plasma pro-
teins. As removal of the hypothetical substances might be expected to
change the filtration barrier toward normal, the effect of plasma
exchange on the protein excretion of the transplanted kidney has been
studied in this condition. A 33-year-old man developed severe steroid-
resistant nephrotic syndrome in February 1978. A renal biopsy revealed
focal segmental glomerulosclerosis. Because of impending protein
malnutrition, a bilateral nephrectomy was performed in September
1978. In May 1979 he received an HLA-identical MLC-unresponding
living donor kidney from his sister and was given immunosuppression
with prednisolone and azathioprine. The grafted kidney functioned
immediately. However, heavy proteinuria was present from the day of
transplantation. A transplant biopsy in September 1979 verified that the
graft lesion was identical to that of his native kidneys. Following a
single plasma exchange with a Plasmaflo hollow fibre membrane filter
(exchanged volume, 2 liters), urinary total protein excretion immediate-
ly decreased from approximately 10 g/24 hours to about 4 to 5 g/24 hours
associated with a 50% decrease of the albumin/creatinine clearance
ratio and a decreased IgG/albumin clearance ratio. The protein excre-
tion gradually increased toward the pre-exchange values during the
following two months. Repeated plasma exchanges in January and June
1980 resulted in decreased protein excretion comparable to that follow-
ing the first exchange. Observations indicate that plasma exchange
decreases the glomerular permeability to plasma proteins in recurrent
renal ailograft focal glomerulosclerosis and are compatible with the idea
that circulating substances interfere with the function of the glomerular
filtration barrier in this condition.
Successful transplantation in preterminal renal failure. J. Acheson, M.
Siakotos, P. Ackrill, R. W. G. Johnson, and N. P. Mallick. Department
ofRenal Medicine and Transplantation Unit, Manchester Royal Infir-
mary, Manchester, England. Clinical experience indicates that patients
with renal failure do not present until symptomatic. The GFR will then
be approximately 10 mI/mm and, once symptomatic, patients tend to go
quickly through to terminal renal failure (GFR 2 mI/mm). We have
demonstrated that serum creatinine levels fitted by a computerized least
squares method to a modified hyperbolic function most closely describe
a linear fall in GFR. The plasma creatinine levels of 55 patients on
hemodialysis were examined retrospectively using this method; it was
shown that once plasma creatinine had reached 600 i.moles/liter (GFR
approximately 10 mI/mm), terminal renal failure ensued in 95% of the
patients within 11.8 months (7.3 4.2 months). The immunological
status of patients was examined at different levels of GFR. Patients with
a GFR of 5 to 10 mI/mm retained immunological competence. These
findings suggested to us that it would be possible to predict the date of
terminal renal failure (GFR 2 mI/mm) and that transplantation should be
safe and feasible with a GFR of approximately 5 to 10 mI/mm. Between
1975 and 1980, 35 patients with a GFR of between 3 and 10 mI/mm were
transplanted without prior dialysis. Results show that these patients did
as well in relation to graft and patient survival as those who were
observed until terminal renal failure occurred and then dialysed to
fitness before transplantation was undertaken.
Metabolism of flurazepam in patients with chronic renal failure: Major
urinary metabolite present in serum for up to three days after a single
dose. M. G. McGeown, H. Delargy, and D. J. Temple. Department of
Nephrology, Belfast City Hospital and Department of Pharmacy,Queen's University, Belfast, Northern Ireland. During 1975 four of our
patients developed an encephalopathy characterized by coarse tremor,
ataxia, and bizarre mental disturbances ending in death after a few
weeks. All the patients had received flurazepam (Dalmane) for night
sedation and had renal transplants which were functioning poorly or not
at all. Several other patients developed minor similar symptoms, but
these disappeared as graft function improved. The use of flurazepam
was banned in the unit; no further patients developed this syndrome. In
1976 Taclob and Needle reported five patients who developed symp-
toms similar to dialysis dementia. All five patients had received
flurazepam as well as other drugs, which, in those patients, included
diazepam. The symptoms cleared in 4 to 5 days afer cessation of the
drugs. In one patient they recurred when flurazepam was given again.
One patient developed similar symptoms after amitriptyline. Fluraze-
pam and amitriptyline both possess dialkylammnoalkyl side-chains at-
tached to their main ring systems. This side-chain makes fiurazepam
unique among the 1,4 benzodiazepine drugs used clinically. It seemed
possible that an encephalopathy might be caused by accumulation of a
metabolite related to this side chain. A high pressure liquid chromato-
graphic assay has been developed for the major metabolites in plasma,
N-desalkyl fiurazepam (NDAF) and hydroxyethyl fiurazepam (HEF),
with a minimum level of sensitivity of 5 ng/ml. The method does not
measure the parent compound. Four patients with chronic renal failure
who were maintained by regular hemodialysis, and one patient with a
marked impairment of renal function (Ccr, 10 mI/mm) were each given
30 mg flurazepam. Blood samples were taken at intervals for up to 3
days and also after hemodialysis. Levels of the HEF conjugate compa-
rable to those found after 1 hour in normal subjects persisted in the
patients up to the last sample taken after 3 days or until dialysis was
performed. The persistence of NDAF did not differ significantly in
patients with renal failure compared with normal subjects, and it was
not removed by dialysis. Regular daily ingestion of fiurazepam by
patients with renal failure led to the accumulation of the HEF conju-
gate. We propose to investigate this metabolite for possible toxicity.
The role of the kidney in mediating endotoxin-induced hypotension. M.
Euden, E. H. F. McGale, J. Bennett, C. Stonier, P. F. Naish, and G.
M. Aber. Department of Postgraduate Medicine, University of Keele,
Keele, Staffordshire, England. The effect of sublethal intravenous
injection of endotoxin (0.5 mg of Escherichia coli 0111 :B4) on blood
pressure, plasma, vascular and renal renin, and prostaglandin activity
was studied in Sprague-Dawley rats. Within 1 hour of the injection a
significant reduction in blood pressure (29 4.1 mm Hg, P < 0.05)
occurred which was sustained for 3 hours. Although the initial fall in
blood pressure was associated with a significant increase in plasma
renin concentration (PRC) from 27.1 3.62 ng Al/mi/hour to 126 28.2
ng Al/mi/hour (P < 0.05), it was only transient; PRC had returned to
preinjection levels by 3 hours despite sustained hypotension. The initial
rise in PRC did not appear to be due to any significant change in renal
renin concentration (RRC) but was associated with a significant reduc-
tion in aortic renin concentration (ARC) from 0.4 0.06 to 0.2 0.06
ng AI/lOO mg/hour (P < 0.01). Recovery of blood pressure to pre-
endotoxin values was achieved by 6 hours without any further changes
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in PRC, RRC, or ARC. Packed cell volume and total plasma protein these experiments similar to those recorded during the initial studies.
concentration remained unaltered throughout the induction and recov- Endotoxin failed to produce any increase in PRC when injected into
ery phases of the study. Significant reductions in total white cell and bilaterally nephrectomized rats. Our studies suggest that endotoxin-
platelet counts were recorded, however. Although these changes oc- induced hypotension is mediated, in part, through the release of a
cuned in association with the initial fall in blood pressure, they vasodilator substance(s), probably prostaglandin, from the kidney. We
persisted despite recovery of the blood pressure to preinjection values, do not exclude the possibility that altered vascular reactivity and/or
Both bilateral nephrectomy and pretreatment with indomethacin pro- changes in other vasoactive compounds may also be involved. It seems
tected the animals from endotoxin-induced hypotension even though unlikely from our observations that activation of either white cells or
endotoxin induced changes in the white cell and platelet counts during platelets is involved in this hemodynamic response to endotoxin.
